靶向药物赫赛汀治疗转移性乳腺癌的研究

乳腺癌为女性常见恶性肿瘤之一，为女性常见癌症第2大死因。乳腺虽不属于人体不可或缺的器官，且原位癌也不致命，随着病情进展速度逐渐加快，癌细胞后期发展至脱落会转移，侵犯至患者心、脑等重要脏器器官，危害患者生命健康。现阶段对乳腺癌相关治疗措施包括手术、放疗、化疗及内分泌治疗等。赫赛汀以癌细胞作为靶点，能进一步抑制转移性乳腺癌发展，本文就近年来所报道的文献结合我院实际开展情况进行以下总结，为后续临床工作者提供理论参考。

Targeted Drug Herceptin in the Treatment of Metastatic Breast Cancer

Breast cancer is one of the common malignant tumors in women, and it is the second leading cause of cancer in women. Although the breast is not an indispensable organ of the human body, and the cancer in situ is not fatal, as the disease progresses, the speed of the cancer gradually increases, and the cancer cells will metastasize and metastasize to metastasize, invading the vital organs of the heart and brain of the patient, and harming the patient. Life is healthy. Current treatments for breast cancer include surgery, radiotherapy, chemotherapy and endocrine therapy. Herceptin can further inhibit the development of metastatic breast cancer by using cancer cells as a target. This paper summarizes the literature reported in recent years and combines the actual development of our hospital to provide a theoretical reference for follow-up clinicians.